These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 8549206

  • 1. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
    Ingram RH.
    Chest; 1996 Jan; 109(1):293. PubMed ID: 8549206
    [No Abstract] [Full Text] [Related]

  • 2. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
    Ikeda A, Nishimura K, Izumi T.
    Chest; 1996 Jan; 109(1):294. PubMed ID: 8549208
    [No Abstract] [Full Text] [Related]

  • 3. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
    Colice GL.
    Am J Med; 1996 Jan 29; 100(1A):11S-18S. PubMed ID: 8610712
    [Abstract] [Full Text] [Related]

  • 4. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
    Pillet O, Manier G, Castaing Y.
    Monaldi Arch Chest Dis; 1998 Feb 29; 53(1):3-8. PubMed ID: 9632900
    [Abstract] [Full Text] [Related]

  • 5. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, McFarland K, Petty TL, Silvers W, Rennard SI, Mueller M, Repsher LH, Zuwallack RL, Vale R.
    Am J Med; 1996 Jan 29; 100(1A):40S-48S. PubMed ID: 8610716
    [Abstract] [Full Text] [Related]

  • 6. [Clinical aspects of anticholinergic agents].
    Friedman M.
    Rev Mal Respir; 1998 Sep 29; 15 Suppl 2():S51-4. PubMed ID: 9809345
    [No Abstract] [Full Text] [Related]

  • 7. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
    Friedman M.
    Am J Med; 1996 Jan 29; 100(1A):30S-39S. PubMed ID: 8610715
    [Abstract] [Full Text] [Related]

  • 8. Anticholinergic bronchodilators.
    Witek TJ.
    Respir Care Clin N Am; 1999 Dec 29; 5(4):521-36. PubMed ID: 10565879
    [Abstract] [Full Text] [Related]

  • 9. Tolerance to beta 2-agonists in patients with chronic obstructive pulmonary disease.
    Georgopoulos D, Wong D, Anthonisen NR.
    Chest; 1990 Feb 29; 97(2):280-4. PubMed ID: 1967572
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease.
    Patakas D, Andreadis D, Mavrofridis E, Argyropoulou P.
    Respir Med; 1998 Sep 29; 92(9):1116-21. PubMed ID: 9926165
    [Abstract] [Full Text] [Related]

  • 12. [A comparison of bronchodilating drugs in the treatment of stable COPD].
    Nishimura K, Koyama H, Izumi T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May 29; 30(5):835-43. PubMed ID: 1385837
    [Abstract] [Full Text] [Related]

  • 13. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.
    Lanes SF, Garrett JE, Wentworth CE, Fitzgerald JM, Karpel JP.
    Chest; 1998 Aug 29; 114(2):365-72. PubMed ID: 9726716
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacodynamics of inhalation broncholytic agents introduced in a single dose by nebulizer in patients with severe exacerbation of bronchial asthma].
    Tsoĭ AN, Apkhipov VV.
    Ter Arkh; 2002 Aug 29; 74(3):17-21. PubMed ID: 11980113
    [Abstract] [Full Text] [Related]

  • 15. A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.
    Matera MG, Caputi M, Cazzola M.
    Respir Med; 1996 Sep 29; 90(8):497-9. PubMed ID: 8869445
    [No Abstract] [Full Text] [Related]

  • 16. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
    Nishimura K, Koyama H, Ikeda A, Sugiura N, Kawakatsu K, Izumi T.
    Chest; 1995 Mar 29; 107(3):718-23. PubMed ID: 7874943
    [Abstract] [Full Text] [Related]

  • 17. Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD?
    Blosser SA, Maxwell SL, Reeves-Hoche MK, Localio AR, Zwillich CW.
    Chest; 1995 Sep 29; 108(3):730-5. PubMed ID: 7656624
    [Abstract] [Full Text] [Related]

  • 18. For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base.
    Campbell S.
    Arch Intern Med; 1999 Jan 25; 159(2):156-60. PubMed ID: 9927098
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence.
    Easton PA, Jadue C, Dhingra S, Anthonisen NR.
    N Engl J Med; 1986 Sep 18; 315(12):735-9. PubMed ID: 2943994
    [Abstract] [Full Text] [Related]

  • 20. Apples and oranges : flaws and guffaws.
    Petty TL.
    Chest; 1999 Oct 18; 116(4):1137-8. PubMed ID: 10531190
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.